[1] WANG Z,WANG S N,XU T Y,et al.Organoid technology for brain and therapeutics research[J].CNS Neurosci Ther,2017,23(10):771.
[2] FATEHULLAH A,TAN S H,BARKER N.Organoids as an in vitro model of human development and disease[J].Nat Cell Biol,2016,18(3):246-254.
[3] HSU P D,LANDER E S,ZHANG F.Development and applications of CRISPR-cas9 for genome engineering[J].Cell,2014,157(6):1262-1278.
[4] CONG L,ZHANG F.Genome Engineering Using CRISPR-Cas9 System[J].Methods Mol Biol,2015,1239:197.
[5] BELENKY P,BOGAN K L,BRENNER C.NAD+ metabolism in health and disease[J].Trends Biochem Sci,2007,32(1):12-19.
[6] WANG P,MIAO C Y.NAMPT as a therapeutic target against stroke[J].Trends Pharmacol Sci,2015,36(12):891-905.
[7] XU R,YUAN Z,YANG L,et al.Inhibition of NAMPT decreases cell growth and enhances susceptibility to oxidative stress[J].Oncol Rep,2017,38(3):1767-1773..
[8] YIN H,VAN DER VEER E,FRONTINI M J,et al.Intrinsic directionality of migrating vascular smooth muscle cells is regulated by NAD+ biosynthesis[J].J Cell Sci,2012,125(23):5770-5780.
[9] VAN DER VEER E,HO C,O'NEIL C,et al.Extension of human cell lifespan by nicotinamide phosphoribosyltransferase[J].J Biol Chem,2007,282(15):10841-10845.
[10] STEIN L R,IMAI S I.Specific ablation of Nampt in adult neural stem cells recapitulates their functional defects during aging[J].Embo J,2014,33:1321-1340.
[11] HENG B C.Effect of Rho-associated kinase (ROCK) inhibitor Y-27632 on the post-thaw viability of cryopreserved human bone marrow-derived mesenchymal stem cells[J].Tissue Cell,2009,41(5):376-380.
[12] GARTEN A,PETZOLD S,KÖRNER A,et al.Nampt:linking NAD biology,metabolism and cancer[J].Trends Endocrinol Metab,2009,20(3):130-138.
[13] REVOLLO J R,KÖRNER A,MILLS K F,et al.Nampt/PBEF/Visfatin regulates insulin secretion in β cells as a systemic NAD biosynthetic enzyme[J].Cell Metab,2007,6(5):363-375.
[14] WANG P,DU H,ZHOU C C,et al.Intracellular NAMPT-NAD+-SIRT1 cascade improves post-ischaemic vascular repair by modulating Notch signalling in endothelial progenitors[J].Cardiovasc Res,2014,104(3):477-488.
[15] WANG P,XU T Y,GUAN Y F,et al.Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1-dependent adenosine monophosphate-activated kinase pathway[J].Ann Neurol,2011,69(2):360-374.